J1580 HCPCS Level II code: Injection, garamycin, gentamicin, up to 80 mg
J1580 is the HCPCS code for “Injection, garamycin, gentamicin, up to 80 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1580Injection, garamycin, gentamicin, up to 80 mg
Short description: Garamycin gentamicin inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J1580 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1984
Where J1580 sits
- 1J codesDrugs administered other than orally
- 2Active code J1580Injection, garamycin, gentamicin, up to 80 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1580 mean?
J1580 is the HCPCS code for “Injection, garamycin, gentamicin, up to 80 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1580?
CMS lists J1580’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1580
All J codesJ1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mgJ1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 mlJ1574Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mgJ1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulinJ1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mgJ1577Injection, immune globulin (qivigy), 100 mgJ1590Injection, gatifloxacin, 10 mgJ1595Injection, glatiramer acetate, 20 mgJ1596Injection, glycopyrrolate, 0.1 mgJ1597Injection, glycopyrrolate (glyrx-pf), 0.1 mgJ1598Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mgJ1599Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg